X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cabazitaxel (579) 579
index medicus (339) 339
docetaxel (333) 333
humans (289) 289
prostate cancer (282) 282
male (260) 260
oncology (230) 230
chemotherapy (220) 220
enzalutamide (156) 156
abiraterone (147) 147
cancer (136) 136
abiraterone acetate (131) 131
mitoxantrone (123) 123
metastasis (117) 117
taxoids - therapeutic use (115) 115
prostatic neoplasms, castration-resistant - drug therapy (114) 114
castration-resistant prostate cancer (113) 113
urology & nephrology (108) 108
antineoplastic agents - therapeutic use (102) 102
prednisone (97) 97
taxoids - administration & dosage (94) 94
mitoxantrone plus prednisone (90) 90
pharmacology & pharmacy (90) 90
aged (87) 87
survival (86) 86
care and treatment (85) 85
increased survival (85) 85
middle aged (78) 78
prostatic neoplasms - drug therapy (78) 78
treatment outcome (77) 77
taxane (76) 76
prostatic neoplasms, castration-resistant - pathology (73) 73
sipuleucel-t (67) 67
medicine & public health (64) 64
taxoids - adverse effects (63) 63
antineoplastic combined chemotherapy protocols - therapeutic use (59) 59
antitumor-activity (58) 58
therapy (58) 58
men (57) 57
paclitaxel (57) 57
every 3 weeks (56) 56
trial (55) 55
analysis (51) 51
neoplasm metastasis (49) 49
prostatic neoplasms - pathology (49) 49
animals (48) 48
castration (48) 48
urology (48) 48
double-blind (47) 47
drug therapy (47) 47
antineoplastic agents - administration & dosage (46) 46
drug resistance, neoplasm (45) 45
research (45) 45
metastatic castration-resistant prostate cancer (44) 44
phenylthiohydantoin - analogs & derivatives (44) 44
prostate (43) 43
androgen receptor (42) 42
taxoids - pharmacology (41) 41
aged, 80 and over (40) 40
antineoplastic agents - adverse effects (39) 39
antineoplastic agents - pharmacology (38) 38
cell line, tumor (38) 38
disease progression (38) 38
hematology, oncology and palliative medicine (38) 38
taxanes (37) 37
antimitotic agents (35) 35
antineoplastic agents (35) 35
plus prednisone (35) 35
cancer therapies (34) 34
denosumab (34) 34
female (34) 34
health aspects (34) 34
open-label (34) 34
tumors (34) 34
disease-free survival (33) 33
development and progression (32) 32
metastases (32) 32
adult (31) 31
radium-223 (31) 31
phase-iii trial (30) 30
phenylthiohydantoin - therapeutic use (30) 30
prostatic neoplasms, castration-resistant - mortality (30) 30
immunotherapy (29) 29
patients (29) 29
toxicity (29) 29
nanoparticles (27) 27
taxoids - pharmacokinetics (27) 27
urologic and male genital diseases (27) 27
article (26) 26
cancer research (26) 26
orchiectomy (26) 26
prognosis (26) 26
prostate-specific antigen - blood (26) 26
androgen antagonists - therapeutic use (25) 25
apoptosis (25) 25
clinical trials (25) 25
drugs (25) 25
pharmacokinetics (25) 25
phase-ii (25) 25
retrospective studies (25) 25
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (512) 512
German (32) 32
French (18) 18
Russian (11) 11
Spanish (6) 6
Czech (4) 4
Portuguese (2) 2
Dutch (1) 1
Hungarian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 02/2018, Volume 36, Issue 6_suppl, pp. 290 - 290
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 03/2019, Volume 25, Issue 6, pp. 1880 - 1888
Patients with metastatic castration-resistant prostate cancer (mCRPC) have several treatment options; however, intrinsic and acquired resistance to various... 
mCRPC | cabazitaxel | ARv567es | AR-V7 | docetaxel
Journal Article
Molecular Cancer Therapeutics, ISSN 1535-7163, 06/2018, Volume 17, Issue 10, pp. molcanther.1269.2017 - 2205
Current treatments for castration resistant prostate cancer (CRPC) largely fall into two classes; AR-targeted therapies such as the next-generation... 
cabazitaxel | abiraterone | docetaxel | prostate cancer resistance | enzalutamide
Journal Article
Onkourologiya, ISSN 1726-9776, 2018, Volume 14, Issue 2, pp. 130 - 141
Prostate cancer is one of the most common causes of death from oncological diseases in men. Taxanes (including docetaxel and cabazitaxel) are... 
Prostate cancer | Cabazitaxel | Docetaxel
Journal Article
Asian Journal of Pharmaceutical Sciences, ISSN 1818-0876, 2018
The potential side effects of cabazitaxel (CBZ) in the field of cancer treatment have become a great limitation to its further clinical application. Liposomal... 
Liposome | Stability | Biosafety | Cabazitaxel | Apoptosis
Journal Article
Gan to kagaku ryoho. Cancer & chemotherapy, ISSN 0385-0684, 06/2016, Volume 43, Issue 6, pp. 777 - 779
Journal Article
Oncotarget, ISSN 1949-2553, 06/2019, Volume 10, Issue 41, p. 4161
Cabazitaxel is a second-generation taxane approved for use in patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with... 
Journal Article
Onkourologiâ, ISSN 1726-9776, 07/2018, Volume 14, Issue 2, pp. 130 - 141
Prostate cancer is one of the most common causes of death from oncological diseases in men. Taxanes (including docetaxel and cabazitaxel) are... 
docetaxel | cabazitaxel | prostate cancer
Journal Article
Lancet Oncology, ISSN 1470-2045, 2015, Volume 16, Issue 2, pp. 152 - 160
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 02/2016, Volume 77, Issue 2, pp. 221 - 233
Journal Article
European Urology, ISSN 0302-2838, 2014, Volume 68, Issue 1, pp. 147 - 153
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10024, pp. 1163 - 1177
Journal Article
European Urology, ISSN 0302-2838, 2011, Volume 60, Issue 2, pp. 279 - 290
Journal Article
European Urology, ISSN 0302-2838, 09/2018, Volume 74, Issue 3, pp. 283 - 291
Noninvasive biomarkers are needed to guide metastatic castration-resistant prostate cancer (mCRPC) treatment. To clinically qualify baseline and on-treatment... 
Circulating cell-free DNA | cfDNA | Docetaxel | PROSELICA | FIRSTANA | Taxane chemotherapy | Cabazitaxel | CIRCULATING DNA | MITOXANTRONE | BIOMARKER | PHASE-III | SERUM | CHEMOTHERAPY | PREDNISONE | ORIGIN | UROLOGY & NEPHROLOGY
Journal Article
Arquivos de Medicina, ISSN 0871-3413, 2015, Volume 29, Issue 1, pp. 2 - 5
Journal Article
Journal Article